Tonix Pharmaceuticals And Bilthoven Biologicals, Part Of The World's Largest Vaccine Manufacturer The Cyrus Poonawalla Group, Which Includes The Serum Institute Of India, Announced A Collaboration To Advance TNX-801, Tonix's Mpox Vaccine Candidate
Portfolio Pulse from Benzinga Newsdesk
Tonix Pharmaceuticals has partnered with Bilthoven Biologicals, part of the Cyrus Poonawalla Group, to advance TNX-801, an Mpox vaccine candidate. This collaboration aims to leverage the expertise of the world's largest vaccine manufacturer.
August 26, 2024 | 11:10 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Tonix Pharmaceuticals has entered a collaboration with Bilthoven Biologicals to advance its Mpox vaccine candidate, TNX-801. This partnership could enhance Tonix's capabilities in vaccine development.
The collaboration with a major player in the vaccine industry could significantly boost Tonix's development of TNX-801, potentially leading to positive investor sentiment and a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90